JP2019506840A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019506840A5 JP2019506840A5 JP2018526142A JP2018526142A JP2019506840A5 JP 2019506840 A5 JP2019506840 A5 JP 2019506840A5 JP 2018526142 A JP2018526142 A JP 2018526142A JP 2018526142 A JP2018526142 A JP 2018526142A JP 2019506840 A5 JP2019506840 A5 JP 2019506840A5
- Authority
- JP
- Japan
- Prior art keywords
- peptide
- peptide according
- sequence
- pharmaceutical composition
- influenza virus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108090000765 processed proteins & peptides Proteins 0.000 claims 39
- 239000008194 pharmaceutical composition Substances 0.000 claims 8
- 238000000034 method Methods 0.000 claims 6
- 241000712461 unidentified influenza virus Species 0.000 claims 4
- 230000009385 viral infection Effects 0.000 claims 4
- 230000000840 anti-viral effect Effects 0.000 claims 3
- 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 claims 3
- 102000039446 nucleic acids Human genes 0.000 claims 3
- 108020004707 nucleic acids Proteins 0.000 claims 3
- 150000007523 nucleic acids Chemical class 0.000 claims 3
- 150000008574 D-amino acids Chemical class 0.000 claims 2
- 241001500351 Influenzavirus A Species 0.000 claims 2
- 150000008575 L-amino acids Chemical class 0.000 claims 2
- 235000001014 amino acid Nutrition 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 102000004196 processed proteins & peptides Human genes 0.000 claims 2
- 101000649167 Xenopus laevis Zinc finger protein Xfin Proteins 0.000 claims 1
- 150000001413 amino acids Chemical class 0.000 claims 1
- 239000000969 carrier Substances 0.000 claims 1
- 239000002872 contrast media Substances 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 206010022000 influenza Diseases 0.000 claims 1
- 208000037798 influenza B Diseases 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 239000013612 plasmid Substances 0.000 claims 1
- 235000018102 proteins Nutrition 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 claims 1
- 230000002685 pulmonary effect Effects 0.000 claims 1
- 150000003384 small molecules Chemical class 0.000 claims 1
- 239000003053 toxin Substances 0.000 claims 1
- 231100000765 toxin Toxicity 0.000 claims 1
- 108700012359 toxins Proteins 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022029519A JP2022088370A (ja) | 2015-11-27 | 2022-02-28 | 抗ウイルス剤としてのペプチドおよびこのための使用 |
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MYPI2015002751 | 2015-11-27 | ||
| MYPI2015002751A MY184269A (en) | 2015-11-27 | 2015-11-27 | Broad-spectrum anti-influenza virus therapeutic peptides |
| US201662335201P | 2016-05-12 | 2016-05-12 | |
| US62/335,201 | 2016-05-12 | ||
| US201662425913P | 2016-11-23 | 2016-11-23 | |
| US62/425,913 | 2016-11-23 | ||
| PCT/IB2016/057146 WO2017090010A1 (en) | 2015-11-27 | 2016-11-28 | Peptides and uses therefor as antiviral agents |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022029519A Division JP2022088370A (ja) | 2015-11-27 | 2022-02-28 | 抗ウイルス剤としてのペプチドおよびこのための使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2019506840A JP2019506840A (ja) | 2019-03-14 |
| JP2019506840A5 true JP2019506840A5 (enExample) | 2020-01-09 |
Family
ID=58763140
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018526142A Pending JP2019506840A (ja) | 2015-11-27 | 2016-11-28 | 抗ウイルス剤としてのペプチドおよびこのための使用 |
| JP2022029519A Pending JP2022088370A (ja) | 2015-11-27 | 2022-02-28 | 抗ウイルス剤としてのペプチドおよびこのための使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022029519A Pending JP2022088370A (ja) | 2015-11-27 | 2022-02-28 | 抗ウイルス剤としてのペプチドおよびこのための使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US10538554B2 (enExample) |
| EP (1) | EP3380493A4 (enExample) |
| JP (2) | JP2019506840A (enExample) |
| CN (1) | CN108699113A (enExample) |
| AU (1) | AU2016359545B2 (enExample) |
| MY (2) | MY184269A (enExample) |
| WO (1) | WO2017090010A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7233737B2 (ja) * | 2017-05-26 | 2023-03-07 | ビラマティクス スンディリアン ブルハド | ペプチドおよび抗ウイルス剤としてのその使用 |
| US20220289794A1 (en) * | 2019-08-29 | 2022-09-15 | AJK Biopharmaceutical, LLC | Synthetic antimicrobial peptides |
| CN111100194B (zh) * | 2020-02-21 | 2022-03-25 | 佛山科学技术学院 | 一种抗菌肽pd-l4在抑制禽流感病毒中的应用 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE369427T1 (de) * | 2001-03-22 | 2007-08-15 | Us Health | Glykosylierungsresistente cyanovirine und damit verbundene konjugate, zusammensetzungen, nukleinsäuren, vektoren, wirtszellen, herstellungsverfahren sowie verfahren zur verwendung nichtglykosylierter cyanovirine |
| US6930085B2 (en) * | 2002-04-05 | 2005-08-16 | The Regents Of The University Of California | G-type peptides to ameliorate atherosclerosis |
| US7148404B2 (en) * | 2004-05-04 | 2006-12-12 | Novozymes A/S | Antimicrobial polypeptides |
| KR20080027777A (ko) * | 2005-06-01 | 2008-03-28 | 배리에이션 바이오테크놀로지스 아이엔씨. | 펩티드기초 인플루엔자 백신 제제 |
| US20070073039A1 (en) * | 2005-09-29 | 2007-03-29 | Chisari Francis V | Peptides that inhibit viral infections |
| GB0718966D0 (en) | 2007-09-28 | 2007-11-07 | Liverpool School Of Tropical M | Bacterial vaccine |
| MY160435A (en) * | 2008-06-12 | 2017-03-15 | Univ Putra Malaysia | A novel antiviral peptide against avian influenza virus h9n2 |
| JP2011524373A (ja) * | 2008-06-13 | 2011-09-01 | ウィスコンシン・アルムナイ・リサーチ・ファウンデーション | インフルエンザウイルスに対する新規抗ウイルスペプチド |
| GB201012651D0 (en) | 2010-07-28 | 2010-09-15 | Univ Edinburgh | Peptides |
| BR112014013853A2 (pt) * | 2011-12-09 | 2020-01-14 | Ceres, Inc. | uso de um ácido nucleico isolado, método de obtenção de uma célula vegetal transgênica, método de obtenção de uma planta transgênica, método de produção de uma planta, método de produção de biomassa, método de processamento de biomassa, método de alteração da composição de biomassa, método de modulação de composição de biomassa, método de produção de um produto de forragem |
| WO2014210454A1 (en) * | 2013-06-27 | 2014-12-31 | Rutgers, The State University Of New Jersey | Treatment and diagnosis of ocular disease |
| JP7233737B2 (ja) * | 2017-05-26 | 2023-03-07 | ビラマティクス スンディリアン ブルハド | ペプチドおよび抗ウイルス剤としてのその使用 |
-
2015
- 2015-11-27 MY MYPI2015002751A patent/MY184269A/en unknown
-
2016
- 2016-11-28 JP JP2018526142A patent/JP2019506840A/ja active Pending
- 2016-11-28 AU AU2016359545A patent/AU2016359545B2/en not_active Ceased
- 2016-11-28 EP EP16868131.0A patent/EP3380493A4/en not_active Withdrawn
- 2016-11-28 MY MYPI2018000817A patent/MY189021A/en unknown
- 2016-11-28 US US15/778,822 patent/US10538554B2/en active Active
- 2016-11-28 CN CN201680079962.8A patent/CN108699113A/zh active Pending
- 2016-11-28 WO PCT/IB2016/057146 patent/WO2017090010A1/en not_active Ceased
-
2022
- 2022-02-28 JP JP2022029519A patent/JP2022088370A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7219258B2 (ja) | ペプチド模倣大環状分子およびその製剤 | |
| JP2012115277A5 (enExample) | ||
| US20130205416A1 (en) | Anti-viral agent | |
| Agamennone et al. | Antiviral peptides as anti-influenza agents | |
| JP2015518818A5 (enExample) | ||
| RU2017119773A (ru) | Пептидные антагонисты пептидных гормонов из семейства кальцитонина (cgrp) и их применение | |
| Martín-Benito et al. | Influenza virus transcription and replication | |
| Gao et al. | Antiviral peptides with in vivo activity: development and modes of action | |
| JP2022088370A (ja) | 抗ウイルス剤としてのペプチドおよびこのための使用 | |
| Astrahan et al. | Resistance characteristics of influenza to amino-adamantyls | |
| HRP20231731T1 (hr) | Peptid za liječenje makularne degeneracije povezane sa starenjem | |
| CN107592865B (zh) | 中和流感病毒的拟肽化合物 | |
| JP2018529625A5 (enExample) | ||
| AU2017350304B2 (en) | Influenza virus neutralizing compounds | |
| RU2005123050A (ru) | Супер-антигенные фьюжн-белки и их использование | |
| HRP20140819T1 (hr) | MUTIRANI TAT OYI PROTEIN ZA PREVENCIJU ILI LIJEÄŚENJE AIDS-a | |
| Air et al. | Influenza virus antiviral targets | |
| NZ740555A (en) | Fusion protein | |
| CN102020702A (zh) | 一种流感a型h3n2病毒血凝素蛋白亲和肽 | |
| NZ740555B2 (en) | Fusion protein | |
| GB2517871A (en) | Alternaria peptides |